European Union -
English -
EMA (European Medicines Agency)
ajovy
teva gmbh - fremanezumab - migraine disorders - calcitonin gene-related peptide (cgrp) antagonists - ajovy is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.
Singapore -
English -
HSA (Health Sciences Authority)
ajovy solution for injection in pre-filled syringe 225 mg1.5ml
teva pharmaceutical investments singapore pte. ltd. - fremanezumab - injection, solution - fremanezumab 225 mg/1.5 ml
Singapore -
English -
HSA (Health Sciences Authority)
ajovy solution for injection in pre-filled pen 225 mg1.5ml
teva pharmaceutical investments singapore pte. ltd. - fremanezumab - injection, solution - fremanezumab 225 mg/1.5ml
Israel -
English -
Ministry of Health
ajovy
abic marketing ltd, israel - fremanezumab - solution for injection - fremanezumab 225 mg / 1.5 ml - ajovy is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.
Canada -
English -
Health Canada
ajovy solution
teva canada limited - fremanezumab - solution - 225mg - fremanezumab 225mg - calcitonin-gene-related peptide (cgrp) antagonists
Canada -
English -
Health Canada
ajovy solution
teva canada limited - fremanezumab - solution - 225mg - fremanezumab 225mg - calcitonin-gene-related peptide (cgrp) antagonists
South Africa -
English -
South African Health Products Regulatory Authority (SAHPRA)
ajovy injection
teva pharmaceuticals (pty) ltd - injection - see ingredients - each syringe or pen contains fremanezumab 225,0 mg
South Africa -
English -
South African Health Products Regulatory Authority (SAHPRA)
fremanezumab teva injection
teva pharmaceuticals (pty) ltd - injection - see ingredients - each syringe or pen contains fremanezumab 225,0 mg
Australia -
English -
Department of Health (Therapeutic Goods Administration)
ajovy fremanezumab 225 mg/1.5 ml solution for injection in a pre-filled syringe
teva pharma australia pty ltd - fremanezumab, quantity: 225 mg - injection, solution - excipient ingredients: histidine hydrochloride monohydrate; histidine; polysorbate 80; disodium edetate; sucrose; water for injections - ajovy is indicated for the preventive treatment of migraine in adults.
Australia -
English -
Department of Health (Therapeutic Goods Administration)
ajovy fremanezumab 225 mg/1.5 ml solution for injection in an autoinjector
teva pharma australia pty ltd - fremanezumab, quantity: 225 mg - injection, solution - excipient ingredients: histidine; disodium edetate; histidine hydrochloride monohydrate; polysorbate 80; sucrose; water for injections - ajovy is indicated for the preventive treatment of migraine in adults.